Double maintains 1 strategies that include ATXS - Astria Therapeutics, Inc.
Yahoo
BOSTON, March 11, 2025--Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today reported financial results for the fourth quarter and full year ended December 31, 2024, and provided a corporate update.
Finnhub
BOSTON - Astria Therapeutics, Inc. , a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, granted stock options to purchase 87,450 shares of...
Yahoo
BOSTON, March 04, 2025--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, granted stock options to purchase 87,450 shares of Astria’s common stock on March 3, 2025 under Astria’s 2022 Inducement Stock Incentive Plan. The 2022 Inducement Stock Incentive Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee of Astria.
Yahoo
BOSTON, February 27, 2025--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced the initiation of the ALPHA-ORBIT Phase 3 clinical trial of navenibart in people living with hereditary angioedema (HAE). Navenibart has the potential to provide rapid and sustained HAE attack prevention with a very low treatment burden and administration every 3 months (Q3M) and every 6 months (Q6M).
Yahoo
BOSTON, February 25, 2025--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that Jill C. Milne, Ph.D., Chief Executive Officer, will participate in a fireside chat at the upcoming TD Cowen 45th Annual Health Care Conference on Tuesday, March 4th at 9:50am ET in Boston, MA.
Yahoo
Key Insights Astria Therapeutics' estimated fair value is US$6.81 based on 2 Stage Free Cash Flow to Equity Current...
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
KYMR | 50.02% | $1.78B | -30.57% | 0.00% |
DNLI | 47.28% | $1.97B | -33.88% | 0.00% |
IMNM | 46.95% | $585.18M | -69.56% | 0.00% |
DIOD | 44.59% | $2.00B | -38.80% | 0.00% |
APGE | 44.59% | $2.22B | -42.57% | 0.00% |
CLDX | 43.85% | $1.20B | -56.41% | 0.00% |
KALV | 43.77% | $573.72M | +1.23% | 0.00% |
BEAM | 42.98% | $1.95B | -40.20% | 0.00% |
CRNX | 42.41% | $3.12B | -27.92% | 0.00% |
OPEN | 41.77% | $737.99M | -64.95% | 0.00% |
ADPT | 41.47% | $1.10B | +138.91% | 0.00% |
ZYME | 41.10% | $835.45M | +20.55% | 0.00% |
SFIX | 40.95% | $418.59M | +22.64% | 0.00% |
RCUS | 40.76% | $830.85M | -57.52% | 0.00% |
FATE | 40.64% | $90.54M | -88.84% | 0.00% |
IDYA | 40.62% | $1.43B | -61.48% | 0.00% |
CRSP | 40.54% | $2.92B | -50.09% | 0.00% |
BNT | 40.37% | $10.49B | +26.90% | 0.00% |
SYRE | 40.33% | $972.25M | -56.39% | 0.00% |
YMAB | 39.96% | $200.32M | -72.64% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
CPRJ | 58.68% | $48.46M | 0.69% |
XBI | 55.22% | $5.33B | 0.35% |
IWC | 53.99% | $810.14M | 0.6% |
RSPA | 52.25% | $290.25M | 0% |
GNOM | 52.07% | $53.29M | 0.5% |
ARKG | 50.76% | $977.87M | 0.75% |
IWO | 49.92% | $10.88B | 0.24% |
IBB | 49.74% | $5.92B | 0.45% |
IWM | 49.52% | $64.21B | 0.19% |
VTWO | 49.39% | $10.91B | 0.07% |
SCHA | 48.36% | $15.95B | 0.04% |
KAPR | 48.08% | $185.00M | 0.79% |
PBE | 47.85% | $233.11M | 0.58% |
KJAN | 47.20% | $318.03M | 0.79% |
ISCG | 47.10% | $654.50M | 0.06% |
GSSC | 46.94% | $512.57M | 0.2% |
ESML | 46.63% | $1.76B | 0.17% |
PRFZ | 46.59% | $2.34B | 0.39% |
IWN | 46.53% | $10.97B | 0.24% |
NUSC | 46.35% | $1.11B | 0.31% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -39.01% | $404.97M | 1.43% |
VIXY | -28.63% | $195.31M | 0.85% |
TAIL | -26.89% | $86.92M | 0.59% |
USDU | -14.18% | $213.46M | 0.5% |
CTA | -10.80% | $963.19M | 0.76% |
UNG | -10.46% | $434.44M | 1.06% |
WEAT | -9.96% | $113.78M | 0.28% |
UUP | -8.86% | $327.80M | 0.77% |
SOYB | -8.26% | $25.81M | 0.22% |
CORN | -8.13% | $51.34M | 0.2% |
DBA | -7.33% | $822.16M | 0.93% |
BUXX | -7.09% | $231.44M | 0.25% |
FXY | -6.59% | $546.19M | 0.4% |
IYK | -5.34% | $1.50B | 0.4% |
BSMW | -4.90% | $100.61M | 0.18% |
CLOI | -4.53% | $1.02B | 0.4% |
TPMN | -4.45% | $33.51M | 0.65% |
ULST | -4.42% | $587.03M | 0.2% |
IBTF | -3.76% | $2.24B | 0.07% |
CARY | -3.60% | $347.36M | 0.8% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PRPO | -0.04% | $9.29M | -8.33% | 0.00% |
CNP | 0.08% | $23.61B | +27.48% | 2.29% |
ROL | 0.12% | $26.21B | +18.18% | 1.17% |
ENB | 0.16% | $96.56B | +23.67% | 6.00% |
MNOV | 0.16% | $71.61M | -0.68% | 0.00% |
CCI | 0.19% | $45.38B | -0.03% | 5.99% |
HOLX | -0.19% | $13.86B | -18.85% | 0.00% |
PM | 0.20% | $246.80B | +73.59% | 3.38% |
LFVN | -0.21% | $183.00M | +128.17% | 1.05% |
HRZN | 0.23% | - | - | 13.97% |
SOLV | 0.23% | $13.16B | +10.04% | 0.00% |
CYCN | 0.26% | $6.78M | -18.57% | 0.00% |
TSCO | 0.27% | $29.29B | +6.68% | 6.42% |
NFG | -0.29% | $7.17B | +48.43% | 2.61% |
CLX | -0.32% | $18.14B | -2.90% | 3.29% |
HRB | 0.33% | $7.35B | +13.87% | 2.61% |
SSL | -0.39% | $2.66B | -45.42% | 0.00% |
AZO | 0.40% | $63.78B | +20.33% | 0.00% |
WCN | 0.42% | $50.38B | +14.56% | 0.61% |
PAA | 0.44% | $14.08B | +12.99% | 6.66% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
ICSH | -0.03% | $5.66B | 0.08% |
FTXG | -0.05% | $25.74M | 0.6% |
TLH | 0.06% | $10.08B | 0.15% |
XLP | -0.06% | $16.50B | 0.09% |
GOVI | -0.08% | $1.06B | 0.15% |
IBTP | 0.12% | $108.59M | 0.07% |
XLU | 0.21% | $17.66B | 0.09% |
SCHR | 0.21% | $10.45B | 0.03% |
CLOA | -0.24% | $786.72M | 0.2% |
TBLL | 0.25% | $2.07B | 0.08% |
SCHQ | -0.30% | $934.09M | 0.03% |
GBIL | 0.34% | $6.31B | 0.12% |
CGCB | -0.37% | $1.99B | 0.27% |
TFI | 0.38% | $3.31B | 0.23% |
IDU | 0.40% | $1.38B | 0.39% |
SPTL | -0.51% | $11.68B | 0.03% |
VGLT | -0.57% | $9.88B | 0.03% |
MMIN | -0.60% | $471.66M | 0.3% |
BCI | 0.61% | $1.43B | 0.26% |
ICLO | 0.69% | $354.53M | 0.2% |
Current Value
$5.321 Year Return
Current Value
$5.321 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
VZ | -20.74% | $190.95B | +7.28% | 5.89% |
CBOE | -17.54% | $23.69B | +24.42% | 1.08% |
K | -16.43% | $28.48B | +44.57% | 2.75% |
CL | -16.37% | $76.00B | +5.21% | 2.12% |
T | -13.11% | $203.00B | +61.60% | 3.91% |
PEP | -13.10% | $205.64B | -13.32% | 3.60% |
AEP | -13.05% | $58.35B | +29.22% | 3.34% |
ED | -12.53% | $39.05B | +22.43% | 3.04% |
HUSA | -10.85% | $12.08M | -45.38% | 0.00% |
CME | -10.70% | $95.61B | +25.13% | 3.98% |
WEC | -10.36% | $34.42B | +33.62% | 3.12% |
CHD | -10.31% | $27.09B | +4.83% | 1.03% |
HSY | -10.03% | $34.64B | -13.74% | 3.19% |
MO | -9.61% | $101.47B | +38.87% | 6.74% |
SO | -9.22% | $100.85B | +29.32% | 3.14% |
COR | -8.85% | $53.93B | +14.44% | 0.76% |
MCK | -8.79% | $84.34B | +25.44% | 0.41% |
LITB | -8.73% | $36.77M | -56.14% | 0.00% |
OHI | -8.60% | $10.73B | +19.67% | 7.00% |
KO | -8.47% | $308.22B | +18.03% | 2.74% |